Catheter Precision Inc (AMEX: VTAK) is 1.77% higher on its value in year-to-date trading and has touched a low of $0.31 and a high of $8.40 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The VTAK stock was last observed hovering at around $0.47 in the last trading session, with the day’s loss setting it -0.01%.
Currently trading at $0.46, the stock is 3.68% and 7.42% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.22 million and changing -1.29% at the moment leaves the stock -80.45% off its SMA200. VTAK registered -88.44% loss for a year compared to 6-month loss of -83.61%. The firm has a 50-day simple moving average (SMA 50) of $0.4274 and a 200-day simple moving average (SMA200) of $2.3506.
The stock witnessed a 29.92% gain in the last 1 month and extending the period to 3 months gives it a 6.50%, and is -13.90% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 17.17% over the week and 15.25% over the month.
Catheter Precision Inc (VTAK) has around 14 employees, a market worth around $3.67M and $0.40M in sales. Profit margin for the company is -2928.32%. Distance from 52-week low is 47.59% and -94.54% from its 52-week high. The company has generated returns on investments over the last 12 months (-48.36%).
with sales reaching $280k over the same period.The EPS is expected to grow by 93.15% this year.
Catheter Precision Inc (VTAK) Top Institutional Holders
10.0 institutions hold shares in Catheter Precision Inc (VTAK), with institutional investors hold 5.39% of the company’s shares. The shares outstanding are 8.00M, and float is at 7.50M with Short Float at 2.55%. Institutions hold 4.66% of the Float.
Catheter Precision Inc (VTAK) Insider Activity
The most recent transaction is an insider purchase by JENKINS DAVID A, the company’s Executive Chairman and CEO. SEC filings show that JENKINS DAVID A bought 9,528 shares of the company’s common stock on Jan 23 ’24 at a price of $0.60 per share for a total of $5694.0. Following the purchase, the insider now owns 0.33 million shares.
Catheter Precision Inc disclosed in a document filed with the SEC on Jan 22 ’24 that JENKINS DAVID A (Executive Chairman and CEO) bought a total of 9,528 shares of the company’s common stock. The trade occurred on Jan 22 ’24 and was made at $0.43 per share for $4092.0. Following the transaction, the insider now directly holds 0.32 million shares of the VTAK stock.
